Nifuroxazide (INN) is an oral nitrofuran antibiotic, patented since 1966 and used to treat colitis and diarrhea in humans and non-humans. It is sold under the brand names Ambatrol, Antinal, Bacifurane, Diafuryl, Pérabacticel (France), Antinal, Diax (Egypt), Nifrozid, Ercefuryl (Romania, Czech Republic, Russia), Erfuzide (Thailand), Endiex (Slovakia), Enterofuryl (Russia), Nifuroksazyd (Poland), Pentofuryl (Germany), Topron, Enterovid (Latin America), Eskapar (Mexico), Apazid (Morocco) and Septidiaryl. It is sold in capsule form and also as a suspension. The pharmaceutical group GlaxoSmithKline plc (Previously known as SmithKline Beecham) claims that nifuroxazide is highly effective and the consumers' group Healthy Skepticism says that GlaxoSmithKline's claims have no scientific support.

CAS：965-52-6
中文别名：4-羟基-2\'-(5-硝基呋喃甲叉)-苯酰肼;硝呋齐特;
英文别名：Ercefuryl;p-hydroxy-N\'-(5-nitrofurfurylidene)benzhydrazide;Nifuroxazida;Ercefurol;Nifuroxazid;Nifuroxazide;Nifuroxazidum [INN-Latin];Dicoferin;Diarlidan;Nifuroxazidum;
分子式：C12H9N3O5
分子量：275.217
精确质量：275.054
Psa：120.65
Logp：2.5714

MDL号：MFCD00079482

外观与性状：黄色固体
密度：1.49 g/cm3
熔点：281-283°C
折射率：1.653
稳定性：Stable at normal temperatures and pressures.
储存条件：Refrigerator, Under Inert Atmosphere

RTECS号：DH2528300
WGK Germany：3
海关编码：2928000090

用途
动物专用新型高效饲料添加剂。